Brief: Precision Biosciences Announces U.S. Patent Covering PBGENE-HBV For Chronic Hepatitis B And Updates Program Status
08/09/2025 12:45
Sept 8 (Reuters) - Precision BioSciences Inc DTIL.O: PRECISION BIOSCIENCES ANNOUNCES U.S. PATENT COVERING PBGENE-HBV FOR CHRONIC HEPATITIS B AND UPDATES PROGRAM STATUS Source text: ID:nBw9glcCMa Further company coverage: DTIL.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Precision Biosciences
See all newsPrecision BioSciences Inc reports results for the quarter ended June 30 - Earnings Summary
Precision BioSciences Q2 net loss widens on warrant liability charge
Precision BioSciences Inc expected to post a loss of 79 cents a share - Earnings Preview
Precision BioSciences Inc expected to post a loss of 79 cents a share - Earnings Preview
Brief: Precision Biosciences - Enters First Amendment To Loan And Security Agreement With Banc Of California - SEC Filing